lobbying_activities: 1083536

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1083536	dc2a868f-49a3-4222-a3bb-f112ac13eb01	Q1	SQUIRE PATTON BOGGS	30906	RANBAXY INC.	2011	first_quarter	PHA	S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Implementation of P.L. 111-152, Health Care & Education Reconciliation; H.R. 4, Comprehensive 1099 Taxpayer Protection and Repaymentof Exchange Subsidy Overpayments Act; S. 23, the America Invents Act; H.R. 1, Full Year Continuing Appropriations Act.	HOUSE OF REPRESENTATIVES,SENATE	160000		0	0	2011-04-19T09:51:30.223000-04:00